Human gene therapy - JoVE Visualize

Showing results (391-400 of 4,122) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|May 16, 2000

Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factorF L Hall, L Liu, N L Zhu, et al.

Human Gene Therapy|May 16, 2000

Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinaseL Yano, M Shimura, M Taniguchi, et al.

Human Gene Therapy|May 16, 2000

Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotypeW Uckert, C Becker, M Gladow, et al.

Human Gene Therapy|May 16, 2000

Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozymeD Klein, C Ricordi, A Pugliese, et al.

Human Gene Therapy|April 25, 2000

Immune responses against replication-deficient adenovirus inhibit ovalbumin-specific allergic reactions in miceM Suzuki, S Suzuki, N Yamamoto, et al.

Human Gene Therapy|April 25, 2000

Antigen-specific induction of peripheral T cell tolerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligandR W Georgantas, K W Leong, J T August

Human Gene Therapy|April 25, 2000

Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vectorD Maione, M Wiznerowicz, P Delmastro, et al.

Human Gene Therapy|April 25, 2000

Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant RevM R Mautino, W J Ramsey, J Reiser, et al.

Human Gene Therapy|May 8, 2001

Immune consequences of intraocular administration of modified adenoviral vectorsM L Suber, M Y Hurwitz, P Chévez-Barrios, et al.

Human Gene Therapy|September 19, 2001

Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agentsG Rappa, A Lorico, M Hildinger, et al.

Pageof 413

Showing results (391-400 of 4,122) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|May 16, 2000

Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factorF L Hall, L Liu, N L Zhu, et al.

Human Gene Therapy|May 16, 2000

Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinaseL Yano, M Shimura, M Taniguchi, et al.

Human Gene Therapy|May 16, 2000

Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotypeW Uckert, C Becker, M Gladow, et al.

Human Gene Therapy|May 16, 2000

Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozymeD Klein, C Ricordi, A Pugliese, et al.

Human Gene Therapy|April 25, 2000

Immune responses against replication-deficient adenovirus inhibit ovalbumin-specific allergic reactions in miceM Suzuki, S Suzuki, N Yamamoto, et al.

Human Gene Therapy|April 25, 2000

Antigen-specific induction of peripheral T cell tolerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligandR W Georgantas, K W Leong, J T August

Human Gene Therapy|April 25, 2000

Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vectorD Maione, M Wiznerowicz, P Delmastro, et al.

Human Gene Therapy|April 25, 2000

Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant RevM R Mautino, W J Ramsey, J Reiser, et al.

Human Gene Therapy|May 8, 2001

Immune consequences of intraocular administration of modified adenoviral vectorsM L Suber, M Y Hurwitz, P Chévez-Barrios, et al.

Human Gene Therapy|September 19, 2001

Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agentsG Rappa, A Lorico, M Hildinger, et al.

Pageof 413